Faculty

All of the faculty associated with the BMS graduate program are listed below. Click on a faculty name to view a detailed description of an individual research program, contact information, recent publications and links to other relevant websites. Each of our faculty is associated with one or more of our eight thematic areas; click on the thematic area name listed by each of our faculty to read more about the research going on in that area, and to view a list of all faculty associated with that thematic area.
 

Rohit Bose, MD, PhD

Primary Thematic Area: 
Cancer Biology & Cell Signaling
Secondary Thematic Area: 
Human Genetics
Research Summary: 
We study tumor evolution, drug sensitization and oncogene network alterations in patients in order to improve precision medicine therapies for hormone-related and genitourinary cancers.
Mentorship Development: 

5/2021 - Sharpening your Mentoring Skills (SyMS)
6/2022 - Career Conversations

Ben Braun, MD, PhD

Primary Thematic Area: 
Cancer Biology & Cell Signaling
Secondary Thematic Area: 
Developmental & Stem Cell Biology
Research Summary: 
Ras signaling in cancer stem cells

Benoit Bruneau, PhD

Primary Thematic Area: 
Developmental & Stem Cell Biology
Secondary Thematic Area: 
Vascular & Cardiac Biology
Research Summary: 
Transcriptional regulation of cardiac morphogenesis and differentiation

Peter Bruno, PhD

Primary Thematic Area: 
Immunology
Secondary Thematic Area: 
Cancer Biology & Cell Signaling
Research Summary: 
We use synthetic biology and high-throughput functional genetic screens to understand antigen presentation and T-cell recognition in the context of cancer and other diseases.
Mentorship Development: 

10-11/2023 - UCSF Inclusive Mentor/Manager Training
11/2024 - The 4 Touchstones of a High-Functioning Mentoring Relationship

Abby Buchwalter, PhD

Primary Thematic Area: 
Developmental & Stem Cell Biology
Secondary Thematic Area: 
Human Genetics
Research Summary: 
We seek to understand how the organization of the nucleus is established, specialized across cell types, and maintained over time to influence cellular identity.
Mentorship Development: 

11/2019 - Equity and Inclusion in the Lab (2 hours)
11/2020 - Optimizing the Efficiency of Your Lab
5/2021 - Sharpening your Mentoring Skills (SyMS)
1/2022 - Equity Based Interview Practices

Jonathan Budzik, MD

Primary Thematic Area: 
Virology & Microbial Pathogenesis
Secondary Thematic Area: 
Immunology
Research Summary: 
We study host and pathogen mechanisms that regulate growth of Mycobacterium tuberculosis and other mycobacteria. We are using proteomic and genetic tools to probe host responses to infection in macrophages and animal models.

Laura Bull, PhD

Primary Thematic Area: 
Human Genetics
Secondary Thematic Area: 
Tissue / Organ Biology & Endocrinology
Research Summary: 
Genetics approaches to study of the biology of the liver in health and disease
Mentorship Development: 

1/2022 - Equity Based Interview Practices

Esteban G. Burchard, MD, MPH

Primary Thematic Area: 
Human Genetics
Secondary Thematic Area: 
None
Research Summary: 
Pharmacogenomics and Genetic Epidemiology of Pulmonary Diseases

Jeffrey Bush, PhD

Primary Thematic Area: 
Developmental & Stem Cell Biology
Secondary Thematic Area: 
Human Genetics
Research Summary: 
Signaling control of mammalian morphogenesis and congenital disease
Mentorship Development: 

5/2021 - Sharpening your Mentoring Skills (SyMS)
6/2022 - Career Conversations

Cathryn Cadwell, MD, PhD

Primary Thematic Area: 
Neurobiology
Secondary Thematic Area: 
Developmental & Stem Cell Biology
Research Summary: 
Development of cortical cell types and circuits

Robin Carhart-Harris, PhD

Primary Thematic Area: 
Neurobiology
Secondary Thematic Area: 
None
Research Summary: 
My research specialism is the brain and therapeutic action of psychedelic drugs.

Julia Carnevale, MD

Primary Thematic Area: 
Immunology
Secondary Thematic Area: 
Cancer Biology & Cell Signaling
Research Summary: 
Our group uses novel gene engineering strategies to decode key genetic programs that we can target to rewire immune cells into effective cancer treatments.

Pages